Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Retained Earnings (2020 - 2025)

Biofrontera has reported Retained Earnings over the past 6 years, most recently at -$127.9 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 8.97% year-over-year to -$127.9 million; the TTM value through Dec 2025 reached -$127.9 million, down 8.97%, while the annual FY2025 figure was -$127.9 million, 8.97% down from the prior year.
  • Retained Earnings for Q4 2025 was -$127.9 million at Biofrontera, up from -$133.6 million in the prior quarter.
  • Over five years, Retained Earnings peaked at -$64.4 million in Q3 2021 and troughed at -$133.6 million in Q3 2025.
  • A 5-year average of -$100.0 million and a median of -$103.2 million in 2023 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: plummeted 91.61% in 2021 and later dropped 0.81% in 2022.
  • Year by year, Retained Earnings stood at -$78.9 million in 2021, then fell by 0.81% to -$79.5 million in 2022, then dropped by 25.32% to -$99.6 million in 2023, then dropped by 17.82% to -$117.4 million in 2024, then dropped by 8.97% to -$127.9 million in 2025.
  • Business Quant data shows Retained Earnings for BFRI at -$127.9 million in Q4 2025, -$133.6 million in Q3 2025, and -$126.9 million in Q2 2025.